17-6451881-C-CAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_031220.4(PITPNM3):c.*3456_*3457insTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.15 ( 667 hom., cov: 20)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PITPNM3
NM_031220.4 3_prime_UTR
NM_031220.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.145
Publications
0 publications found
Genes affected
PITPNM3 (HGNC:21043): (PITPNM family member 3) This gene encodes a member of a family of membrane-associated phosphatidylinositol transfer domain-containing proteins. The calcium-binding protein has phosphatidylinositol (PI) transfer activity and interacts with the protein tyrosine kinase PTK2B (also known as PYK2). The protein is homologous to a Drosophila protein that is implicated in the visual transduction pathway in flies. Mutations in this gene result in autosomal dominant cone dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
PITPNM3 Gene-Disease associations (from GenCC):
- cone-rod dystrophy 5Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_031220.4. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.147 AC: 5448AN: 37068Hom.: 660 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
5448
AN:
37068
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 28Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 16
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
28
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
16
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
24
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.147 AC: 5468AN: 37092Hom.: 667 Cov.: 20 AF XY: 0.151 AC XY: 2766AN XY: 18266 show subpopulations
GnomAD4 genome
AF:
AC:
5468
AN:
37092
Hom.:
Cov.:
20
AF XY:
AC XY:
2766
AN XY:
18266
show subpopulations
African (AFR)
AF:
AC:
1887
AN:
9628
American (AMR)
AF:
AC:
267
AN:
3336
Ashkenazi Jewish (ASJ)
AF:
AC:
77
AN:
1032
East Asian (EAS)
AF:
AC:
269
AN:
1606
South Asian (SAS)
AF:
AC:
247
AN:
942
European-Finnish (FIN)
AF:
AC:
437
AN:
3056
Middle Eastern (MID)
AF:
AC:
9
AN:
126
European-Non Finnish (NFE)
AF:
AC:
2201
AN:
16728
Other (OTH)
AF:
AC:
62
AN:
490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.643
Heterozygous variant carriers
0
142
284
427
569
711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.